Résultats de la recherche - Merel Willekes
- Résultat(s) 1 - 2 résultats de 2
-
1
MEK inhibition is a promising therapeutic strategy for <i>MLL</i>-rearranged infant acute lymphoblastic leukemia patients carrying <i>RAS</i> mutations par Mark Kerstjens, Emma M. C. Driessen, Merel Willekes, Sandra S. Pinhanços, Pauline Schneider, Rob Pieters, Ronald W. Stam
Publié 2016Artigo -
2
Outils de recherche:
Sujets similaires
Biology
Cancer research
Genetics
Apoptosis
Cancer
Cell biology
Cell cycle
Cell growth
Colorectal cancer
Cyclin-dependent kinase
Cyclin-dependent kinase 6
Gene
HRAS
Hematology
Internal medicine
KRAS
Kinase
Leukemia
Lymphoblastic Leukemia
MAPK/ERK pathway
MEK inhibitor
Medicine
Mutant
Oncology
Selumetinib
Trametinib
Wild type